171 related articles for article (PubMed ID: 31166141)
1. Sterically stabilized siRNA:gold nanocomplexes enhance
Daniels AN; Singh M
Nanomedicine (Lond); 2019 Jun; 14(11):1387-1401. PubMed ID: 31166141
[No Abstract] [Full Text] [Related]
2. Modified gold nanoparticles for intracellular delivery of anti-liver cancer siRNA.
Shaat H; Mostafa A; Moustafa M; Gamal-Eldeen A; Emam A; El-Hussieny E; Elhefnawi M
Int J Pharm; 2016 May; 504(1-2):125-33. PubMed ID: 27036397
[TBL] [Abstract][Full Text] [Related]
3. Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
Guo J; O'Driscoll CM; Holmes JD; Rahme K
Int J Pharm; 2016 Jul; 509(1-2):16-27. PubMed ID: 27188645
[TBL] [Abstract][Full Text] [Related]
4. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells.
Sardo C; Bassi B; Craparo EF; Scialabba C; Cabrini E; Dacarro G; D'Agostino A; Taglietti A; Giammona G; Pallavicini P; Cavallaro G
Int J Pharm; 2017 Mar; 519(1-2):113-124. PubMed ID: 28093325
[TBL] [Abstract][Full Text] [Related]
5. Precise engineering of siRNA delivery vehicles to tumors using polyion complexes and gold nanoparticles.
Kim HJ; Takemoto H; Yi Y; Zheng M; Maeda Y; Chaya H; Hayashi K; Mi P; Pittella F; Christie RJ; Toh K; Matsumoto Y; Nishiyama N; Miyata K; Kataoka K
ACS Nano; 2014 Sep; 8(9):8979-91. PubMed ID: 25133608
[TBL] [Abstract][Full Text] [Related]
6. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility.
Han L; Zhao J; Zhang X; Cao W; Hu X; Zou G; Duan X; Liang XJ
ACS Nano; 2012 Aug; 6(8):7340-51. PubMed ID: 22838646
[TBL] [Abstract][Full Text] [Related]
7. Efficient delivery of therapeutic siRNA into glioblastoma cells using multifunctional dendrimer-entrapped gold nanoparticles.
Kong L; Wu Y; Alves CS; Shi X
Nanomedicine (Lond); 2016 Dec; 11(23):3103-3115. PubMed ID: 27809656
[TBL] [Abstract][Full Text] [Related]
8. Layer by Layer Assembled Chitosan-Coated Gold Nanoparticles for Enhanced siRNA Delivery and Silencing.
Shaabani E; Sharifiaghdam M; De Keersmaecker H; De Rycke R; De Smedt S; Faridi-Majidi R; Braeckmans K; Fraire JC
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467656
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the physicochemical properties and the biocompatibility of polyethylene glycol-conjugated gold nanoparticles: A formulation strategy for siRNA delivery.
Rahme K; Guo J; Holmes JD; O'Driscoll CM
Colloids Surf B Biointerfaces; 2015 Nov; 135():604-612. PubMed ID: 26322474
[TBL] [Abstract][Full Text] [Related]
10. Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells.
Rahme K; Guo J; Holmes JD
Methods Mol Biol; 2019; 1974():291-301. PubMed ID: 31099011
[TBL] [Abstract][Full Text] [Related]
11. Dendrimer functionalized folate-targeted gold nanoparticles for luciferase gene silencing in vitro: A proof of principle study.
Mbatha LS; Maiyo FC; Singh M
Acta Pharm; 2019 Mar; 69(1):49-61. PubMed ID: 31259716
[TBL] [Abstract][Full Text] [Related]
12. Gold nanoparticle-siRNA mediated oncogene knockdown at RNA and protein level, with associated gene effects.
Child HW; Hernandez Y; Conde J; Mullin M; Baptista P; de la Fuente JM; Berry CC
Nanomedicine (Lond); 2015; 10(16):2513-25. PubMed ID: 26302331
[TBL] [Abstract][Full Text] [Related]
13. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
14. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery.
Song WJ; Du JZ; Sun TM; Zhang PZ; Wang J
Small; 2010 Jan; 6(2):239-46. PubMed ID: 19924738
[TBL] [Abstract][Full Text] [Related]
15. Amphiphilic gold nanoparticles displaying flexible bifurcated ligands as a carrier for siRNA delivery into the cell cytosol.
Niikura K; Kobayashi K; Takeuchi C; Fujitani N; Takahara S; Ninomiya T; Hagiwara K; Mitomo H; Ito Y; Osada Y; Ijiro K
ACS Appl Mater Interfaces; 2014 Dec; 6(24):22146-54. PubMed ID: 25466488
[TBL] [Abstract][Full Text] [Related]
16. In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models.
Conde J; Tian F; Hernández Y; Bao C; Cui D; Janssen KP; Ibarra MR; Baptista PV; Stoeger T; de la Fuente JM
Biomaterials; 2013 Oct; 34(31):7744-53. PubMed ID: 23850099
[TBL] [Abstract][Full Text] [Related]
17. Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.
Ragelle H; Riva R; Vandermeulen G; Naeye B; Pourcelle V; Le Duff CS; D'Haese C; Nysten B; Braeckmans K; De Smedt SC; Jérôme C; Préat V
J Control Release; 2014 Feb; 176():54-63. PubMed ID: 24389132
[TBL] [Abstract][Full Text] [Related]
18. Chitosan/siRNA functionalized titanium surface via a layer-by-layer approach for in vitro sustained gene silencing and osteogenic promotion.
Song W; Song X; Yang C; Gao S; Klausen LH; Zhang Y; Dong M; Kjems J
Int J Nanomedicine; 2015; 10():2335-46. PubMed ID: 25848254
[TBL] [Abstract][Full Text] [Related]
19. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K
J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214
[TBL] [Abstract][Full Text] [Related]
20. Gold Nanoparticles Conjugated with Dendrigraft Poly-L-lysine and Folate-Targeted Poly(ethylene glycol) for siRNA Delivery to Prostate cancer.
Minassian G; Ghanem E; Hage RE; Rahme K
Nanotheranostics; 2023; 7(2):152-166. PubMed ID: 36793347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
